Amicus Therapeutics (FOLD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Sales | 64,358 | 14,967 | 1,784 | 1,784 | 0 |
| Gross Profit | 64,358 | 14,967 | 1,784 | 1,784 | N/A |
| Operating Expenses | 71,708 | 58,923 | 47,589 | 47,589 | 20,832 |
| Operating Income | -7,350 | -43,956 | -45,805 | -45,805 | -20,832 |
| Interest Expense | 278 | 218 | 348 | 348 | 82 |
| Other Income | 1,061 | 4,819 | 4,986 | 4,986 | 330 |
| Pre-tax Income | -6,567 | -39,355 | -41,167 | -41,167 | -20,584 |
| Income Tax | 0 | N/A | N/A | N/A | -612 |
| Net Income Continuous | -6,567 | -39,355 | -41,167 | -41,167 | -19,972 |
| Net Income | $-6,567 | $-39,355 | $-41,167 | $-41,167 | $-19,972 |
| EPS Basic Total Ops | -0.29 | -1.75 | -3.14 | -89.58 | -49.02 |
| EPS Basic Continuous Ops | -0.29 | -1.75 | -3.11 | -55.93 | -48.71 |
| EPS Diluted Total Ops | -0.29 | -1.75 | -3.14 | -89.58 | -49.02 |
| EPS Diluted Continuous Ops | -0.29 | -1.75 | -3.11 | -55.93 | -48.71 |
| EBITDA(a) | $-5,218 | $-42,463 | $-44,568 | $-44,853 | $-20,164 |